Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Incyte Corp (NQ: INCY )

90.56 USD UNCHANGED
Streaming Delayed Price Updated: 7:01 AM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Incyte Corp

< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)
Investors should take notice of this four-way competition. 
Tags ABBV Market News LLY
From Motley Fool
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags STIM BIOL KLDO
From Benzinga
MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
From ACCESSWIRE
Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
From PR Newswire
Benzinga's Top Upgrades, Downgrades For January 7, 2021
Upgrades According to Citigroup, the prior rating for Sealed Air Corp (NYSE:SEE) was changed from Neutral to Buy. For ... 
Tags Benzinga ADS NOAH
From Benzinga
Why These Health Care Stocks Are Moving Today
Altimmune (NASDAQ: ALT) shares weretrading higher Wednesday after the company announced it began a multinational Phase 2 clinical ... 
Tags News OSMT BCDA
From Benzinga
Nasdaq 100 Movers: SGEN, BIDU
In early trading on Wednesday, shares of Baidu topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.7%. Year to date, Baidu registers a 63.0% gain. 
Tags Stocks
From Market News Video
Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 
From Business Wire News Releases
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning the emergence of a new strain of coronavirus in the U.K. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning ... 
Tags RDHL SBTX RHHBY
From Benzinga
Nasdaq 100 Movers: ZM, ALXN
In early trading on Monday, shares of Alexion Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index, trading up 30.7%. Year to date, Alexion Pharmaceuticals... 
Tags Stocks
From Market News Video
S&P 500 Movers: HBAN, ALXN
In early trading on Monday, shares of Alexion Pharmaceuticals topped the list of the day's best performing components of the S&P 500 index, trading up 30.4%. Year to date, Alexion Pharmaceuticals... 
Tags Stocks
From Market News Video
Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi®) as a Treatment for Patients with COVID-19 Associated Cytokine Storm
Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi®) as a Treatment for Patients with COVID-19 Associated Cytokine Storm 
From Business Wire News Releases
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial... 
From PR Newswire
Incyte to Present at Upcoming Investor Conference
Incyte (Nasdaq:INCY) announced today that it will present at the 39th Annual J. P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 7:30 a.m. EST. 
From Business Wire News Releases
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags HALO PFE Biotech
From Benzinga
7 Biotechs Moving On Hematology Conference Presentations
The American Society of Hematology conference kicked off Saturday and has driven several directional movesin the stock ... 
Tags CNST GMDA Movers
From Benzinga
Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020
From ACCESSWIRE
Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with r/r B-Cell Non-Hodgkin Lymphomas 
From Business Wire News Releases
Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020
Data Evaluating Tafasitamab with and without Lenalidomide in Combination with R-CHOP in Patients with DLBCL Presented at ASH 2020 
From Business Wire News Releases
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags IMRA ALVR NVAX
From Benzinga
Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi®) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
First Data from REACH3 Show Ruxolitinib (Jakafi) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent cGVHD 
From Business Wire News Releases
New Pharma Trials Making Big Gains in Fight Against Triple-Negative Breast Cancer (TNBC)
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
New Pharma Trials Making Big Gains in Fight Against Triple-Negative Breast Cancer (TNBC)
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DTIL Benzinga CORT
From Benzinga
Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
- ACTT-2 data serve as basis for EUA, the second COVID-19 authorization for a Lilly treatment 
From PR Newswire
Sum Up The Parts: CURE Could Be Worth $76
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Incyte to Present at Upcoming Investor Conference
Incyte (Nasdaq:INCY) announced today that it will present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, December 1, 2020 at 10:30 a.m. EST. 
From Business Wire News Releases
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DYAI RDHL HSDT
From Benzinga
Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
Xencor (NASDAQ: XNCR), MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) and Incyte (NASDAQ: INCY) today announced a clinical collaboration to investigate the combination of... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.